- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Hatim Husain, MD | Authors
Articles
Monitoring the Emergence of T790M in EGFR-Mutated Lung Cancer
February 04, 2017
Video
Hatim Husain, MD, assistant professor of Hematology-Oncology at the University of California San Diego Moores Cancer Center, discusses a study monitoring the emergence of T790M in EGFR-mutated non-small cell lung cancer (NSCLC).